Page 18 - Pharma

Narayana Health partners with Cisco to offer specialised remote diagnostics capabilities

The association will enable Narayana Health to offer high-quality diagnostic services for various specialities at a cost that's affordable to patients remotely in various parts of the country

Indoco Remedies receives six 483s for Goa plant from US FDA

Form 483s were issued after the US drug regulator inspected the company's Goa plant II in connection with ANDA filings for injectable

Sonoco ThermoSafe buys AAR cold chain solutions assets

By acquiring PharmaPort 360, it has entered the market of active temperature-controlled cargo containers, which are mainly used for shipping pharmaceuticals and biologics globally

Syngene opens R&D centre for Amgen in Bangalore

This will be Syngene's fourth such exclusive R&D centre. It already operates dedicated R&D centres for Bristol-Myers Squibb, Abbott Nutrition and Baxter Inc

Germany's Fresenius Medical buys dialysis service provider Sandor Nephro

With the acquisition of Sandor Nephro Services, which operates under the brand name Sparsh Nephrocare, the German firm will strengthen its dialysis business in India

Glenmark discovers new biologic drug for cancer treatment

The company is likely to file an investigational new drug (IND) application with the US FDA for the new drug, GBR 1372, in the second half of the next financial year FY 2018

Lupin receives US FDA tentative approval for antibacterial drug moxifloxacin

The approved product, moxifloxacin hydrochloride tablet, is a generic version of Bayer Healthcare's Avelox tablet

Dr Reddy's launches antidepressant drug bupropion in US

Bupropion HCl extended-release tablet (SR) is a generic version of GSK's Wellbutrin SR tablet, which is a medication primarily used as an antidepressant and smoking cessation aid

Natco's partner Mylan invalidates third Teva Copaxone patent in US

Earlier, on August 24, 2016, the US patent office invalidated two of the patents of Teva protecting Copaxone (glatiramer acetate) 40 mg dosage injection

Medical device parks to bring down manufacturing cost by 30%

GST will further bring down the taxation in the sector by almost 12 per cent, according to Ananth Kumar, Minister for Chemicals and Fertilizers

Sun Pharma ropes in Mitsubishi Tanabe to distribute products in Japan

Mitsubishi Tanabe Pharma Corporation will market and distribute 14 brands, which were acquired by Sun Pharma earlier this year from Novartis Pharma KK

Cadila Healthcare receives US FDA's EIR report for facility in Ahmedabad SEZ

The company has received an establishment inspection report (EIR) from the US drug regulator for its oral solid dosage drug manufacturing plant

Lupin gets US FDA nod for antibacterial drug azithromycin suspension

The approved product - azithromycin for oral suspension, 300 mg (100 mg/5 mL) and 1200 mg (200 mg/5 mL) - is the generic version of Pfizer Inc's Zithromax oral suspension

Standards and certifications are must for India's industrial growth story

To accelerate towards the twin goals of product safety and quality, industries in India must proactively participate to create a robust system of standards and regulations, says Suresh Sugavanam

Bioelectronics open up another leg of medical therapy: Dr Mosongo Moukwa

The success of bioelectronic medicine will require the confluence of deep disease biology expertise and new highly miniaturised technologies

Pfizer buys AstraZeneca's small molecule antibiotics business for $ 725 mn

With this agreement, AstraZeneca reinforces its focus on developing novel medicines in three main therapy areas - respiratory & autoimmunity, cardiovascular & metabolic diseases, and oncology

Bal Pharma appoints Akash Mathur as CEO

Mathur has vast pharma experience in the US & Canada including a start-up and advisory role to several small and medium companies followed by 10 years of working leading pharma companies

Claris Lifesciences receives US FDA approval for flumazenil injection

The approved product, which is primarily used to help reverse anaesthesia effect, is estimated to have market size of $ 4 million in the US

Claris Injectables receives five 483s from US FDA for plant in Ahmedabad

The company received 483s after US FDA's inspection, classified as prior approval inspection (PAI), which was conducted from August 16 to August 26, 2016

NPPA launches mobile App to provide real time drug prices

In the last two and a half years, National Pharmaceutical Pricing Authority (NPPA) has brought almost 900 formulations under the price control